KROS earnings: a negative outcome, -6.9%

On August 7, 2024, Keros Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -6.9% in the window around the event. It had already run +17.9% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.